5:29 PM
 | 
Oct 18, 2013
 |  BC Extra  |  Politics & Policy

FDA to extend biosimilar deadlines due to shutdown

FDA told BioCentury it plans to extend by the number of days the federal government was shut down the deadlines and goal dates for its biosimilars activities, including deadlines for IND meetings with sponsors. Because the biosimilar user fee program was...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >